透過您的圖書館登入
IP:3.16.47.14
  • 學位論文

在lovastatin生產菌Aspergillus terreus ATCC 20542醱酵過程中,探討代謝物之生產與菌株增長形態之變化

Metabolite production and morphological changes by a lovastatin-producing fungus Aspergillus terreus ATCC 20542

指導教授 : 賴龍山
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


一般認為,溶氧(dissolved oxygen,簡稱 DO)控制真菌代謝物之生產;本研究利用Aspergillus terreus ATCC 20542在五公升醱酵槽中進行不同時機(0-144 h)的DO控制實驗。實驗結果顯示itaconic acid (IA)與lovastatin之產量均以DO 20%(0 h)為最高產量,而兩者亦均以攪拌控制(200 rpm)為最低。且在各不同時機之控制條件下,IA 與lovastatin之產量均呈類比關係,隱含「IA分子可能僅提供lovastatin合成之某種官能基團」之意。此外,本研究也發現此菌絲的增長型態在醱酵槽中會影響代謝物的生產,IA產量主要與「菌株平均粒徑」有關,而lovastatin產量則以「菌絲顆粒密度」為最重要。

並列摘要


It is generally recognized that the level of DO (dissolved oxygen) controls metabolite production by fungi. Using Aspergillus terreus ATCC20542, a control of DO 20% was applied starting from a different timing (0-144 h) of a 5 L fermentation. The results showed that both of the production of itaconic acid (IA) and lovastatin were optimized under DO 20% (0 h), whereas the both were minimized under 200 rpm. The experimental results implied that IA might play a role or act as a group donor in the lovastatin synthesis by the fungus since both seemed to display a proportional production kinetics. Furthermore, the fungal morphology strongly influenced metabolite production. IA synthesis was closely associated with pellet size distribution; meanwhile, lovastatin production was mainly related to pellet density.

參考文獻


蕭明熙,「降膽固醇與抗動脈粥狀硬化藥物」。中國化學會誌,第五十二期,第442-453頁(1994)。
蘇遠志、黃世佑,微生物化學工程學,華香園出版社,台北(1994)。
Lai, L.-S.T., Kuo, C.M., and Tsai, S.Y., “Influence of increased dissolved oxygen tensions by agitation on the secondary metabolite production by a mutant of Aspergillus terreus in a 5L fermentor.” J. Chin. Inst. Chem. Eng., Vol.32 pp.135-142(2001).
洪鳳鳴,「在真菌Aspergillus terreus ATCC 20542醱酵生產lovastatin的過程中,探討溶氧對其共同代謝物itaconic acid (IA)生產之影響」,碩士論文,私立朝陽科技學應用化學系,台中(2008)。
劉秋幸,「利用Aspergillus terreus ATCC 20542生產降膽固醇劑lovastatin之研究-菌種改良與生產條件之探討」,碩士論文,台灣大學農業化學研究所,台北(1995)。

延伸閱讀